From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Amaroq Minerals – now also identifies high-grade gold at Eagle’s Nest target, BUY at 97p, target increased to 150p plus

By Tom Winnifrith & Steve Moore | Friday 13 December 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Amaroq Minerals (AMRQ) has announced that sampling at the Eagle’s Nest target 31 kilometres from its Nalunaq gold mine in Greenland has identified two distinct sub-parallel gold veins and gold grades up to 54.5g/t, with “initial geochemical results suggestive of a similar mineralisation style to Nalunaq”. This looks to further demonstrate the exploration, as well as production, potential we’ve been emphasising here. And this is critical for Nalunaq on its own justifies a premium to the current share price but it is the massive exploration potential that will attract potential corporate bidders within a couple of years. The faster Amaroq explores, with results like these, the more a bidder will have to pay.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 02:34:20